Celularity banks $12m to refocus its longevity ambitions
Longevity Technology - 19-Dec-2025New funding gives the regenerative biotech breathing space to prioritise placental cell therapies
Investments News
GlycanAge lands 7.4m to take ageing tests mainstream
EU-Startups - 18-Dec-2025New funding backs glycan biomarkers to help doctors track inflammation and biological age
Rejuvenating aging: how LEVF aims to treat the root cause of disease
LEV Foundation - 17-Dec-2025Combining repair therapies in mice could redefine how science tackles aging itself
DNA Nanobots raises $3.5m to push non-viral gene delivery T
Business Wire - 17-Dec-2025Fresh funding backs DNA origami nanobots aimed at safer, more precise gene therapies
From code to cures: Chai Discovery’s big AI bet
TechCrunch - 15-Dec-2025OpenAI-backed Chai raises $130M to accelerate drug and antibody design with AI
Robots, AI, and the race to decode aging
Longevity Technology - 12-Dec-2025A “lab-in-a-loop” platform could speed longevity drug discovery by learning from every experiment
Nanotech BCI breakthrough wins new funding
Longevity Technology - 11-Dec-2025Subsense advances non-surgical BCI tech with new $10M to speed preclinical research
The surgeon who wants robots to democratize healthcare
Forbes - 05-Dec-2025Robotics pioneer Fred Moll backs AI-powered machines to expand access to complex surgery worldwide
Junevity raises $20M to advance siRNA-based cellular reprogramming
Longevity Technology - 03-Dec-2025siRNA therapy JUN_01 aims to reset metabolic tissues and improve long-term metabolic health
Can cleaning your blood be the next big longevity trend?
HIT Consultant - 03-Dec-2025Startup bets on plasma exchange to tackle microplastics, toxins, and chronic inflammation
Circular Genomics raises $15M for early Alzheimer’s detection
Longevity Technology - 02-Dec-2025Blood-based circRNA signatures aim to spot Alzheimer’s risk years before symptoms appear
AGC Biologics and Repair Bio unite to advance plaque-clearing mRNA treatment
Longevity Technology - 25-Nov-2025The teams aim to create an mRNA therapy that breaks down toxic cholesterol inside artery cells
The young founder teaching big pharma a new way to reverse aging
LEVITY - 21-Nov-2025Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases
Unlocking longevity through smart diagnostics
Live Forever Club - 18-Nov-2025New Hevolution–Nanobiosym deal accelerates AI-driven metabolic and ageing diagnostics
Rewriting disease: Scripta Therapeutics targets the cell’s master switches
Longevity Technology - 17-Nov-2025Startup uses transcription factor mapping to find disease-modifying treatments for neurodegeneration
AbbVie ends 11-year Calico partnership focused on aging research
FierceBiotech - 12-Nov-2025AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
Lab-grown cells could reduce the need for donor transplants
Longevity Technology - 12-Nov-2025The company hopes to begin human testing in the next few years
Lilly expands $100M AI drug discovery deal with Insilico Medicine
Longevity Technology - 11-Nov-2025Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
Inbrain teams with Microsoft to advance AI-powered brain implants
FierceBiotech - 11-Nov-2025Graphene-based BCIs use Azure AI to adapt in real time for Parkinson’s and stroke therapy
Synchron raises $200M to advance thought-controlled tech
MobiHealthNews - 06-Nov-2025Funding accelerates Stentrode’s clinical progress and hands-free device control for paralysis
Chan and Zuckerberg shift philanthropy toward AI-driven biomedical research
Independent - 06-Nov-2025Biohub will invest ~$1B a year to build AI-driven virtual cells and speed disease research
Roche taps Manifold Bio to cross the brain barrier
FierceBiotech - 03-Nov-2025$2B deal aims to develop AI-guided shuttles to carry therapies across the blood-brain barrier
Cyclana Bio: redefining women’s health
Longevity Technology - 30-Oct-2025Using menstrual fluid, Cyclana builds tissue models to tackle endometriosis and chronic inflammation
Mission raises $13.3m for Parkinson’s mitophagy drug
Longevity Technology - 27-Oct-2025Cambridge biotech to trial USP30 inhibitor MTX325 to boost mitochondrial repair in Parkinson’s
OrganOx sold for $1.5bn after creating device that keeps donor livers alive longer
BGF - 25-Oct-2025The deal shows how long-term backing can help medical ideas reach real patients
Display all news
